The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay.
Jeong
Young-Hoon
YH
Kim
In-Suk
IS
Choi
Bong-Ryong
BR
Kwak
Choong Hwan
CH
Hwang
Jin-Yong
JY
D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D023921:Coronary Stenosis / Q000628:therapy*; D003328:Coronary Thrombosis / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D013988:Ticlopidine / Q000031:analogs & derivatives*
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine